Related Experiment Video
Updated: Dec 17, 2025
Peptide-based Identification of Functional Motifs and their Binding Partners
Published on: June 30, 2013
Bee venom-derived antimicrobial peptide melectin has broad-spectrum potency, cell selectivity, and salt-resistant
Su Jin Ko1, Eunji Park1, Alina Asandei2
1Department of Biomedical Science, Chosun University, Gwangju, 61452, South Korea.
Abstract:
Antimicrobial peptides have attracted attention as alternatives to conventional antibiotics. Previously, a novel antimicrobial peptide, melectin, consisting of 18 amino acids was isolated from the venom of a bee, Melecta albifrons. Here, we investigated the antibacterial activity of melectin against drug-resistant bacteria. Melectin showed broad-spectrum antimicrobial activity but low cytotoxicity and no hemolytic activity. Melectin maintained its antimicrobial activity at physiological salt concentrations. Melectin is an α-helical structure that binds to the bacterial membrane via electrostatic interactions and kills bacteria in a short time by bacterial membrane targeting. Collectively, our results suggest that melectin has antibacterial activity and anti-inflammatory activity.
Insights
Melectin, a novel antimicrobial peptide from bee venom, effectively combats drug-resistant bacteria. This peptide exhibits broad-spectrum activity, low toxicity, and anti-inflammatory properties, offering a promising alternative to traditional antibiotics.
Area of Science:
- Biochemistry
- Microbiology
- Pharmacology
Background:
- Antimicrobial peptides (AMPs) are emerging as alternatives to conventional antibiotics.
- Melectin, an 18-amino acid peptide, was previously isolated from Melecta albifrons bee venom.
Purpose of the Study:
- To investigate the antibacterial activity of melectin against drug-resistant bacteria.
- To evaluate the safety profile and mechanism of action of melectin.
Main Methods:
- Antibacterial assays against various bacterial strains, including drug-resistant ones.
- Cytotoxicity and hemolytic activity assays.
- Structural analysis and membrane interaction studies.
Main Results:
- Melectin demonstrated broad-spectrum antimicrobial activity against drug-resistant bacteria.
- The peptide exhibited low cytotoxicity and no hemolytic activity.
- Melectin functions as an alpha-helical peptide, targeting bacterial membranes via electrostatic interactions.
- Antimicrobial activity was maintained at physiological salt concentrations.
Conclusions:
- Melectin possesses significant antibacterial potential against resistant pathogens.
- Its favorable safety profile and membrane-targeting mechanism suggest therapeutic promise.
- Melectin also exhibits anti-inflammatory activity, broadening its potential applications.
